Market Overview

Theragenics Signs Agreement with GE Healthcare Unit

Related TGX
Theragenics Reports End of Go-Shop Period, Says No Parties Submitted Proposal to Buy
UPDATE: Juniper to Buy Theragenics at $2.20/Share in Cash

Theragenics Corporation (NYSE: TGX) today announced it has signed a value-added loading services
agreement with Oncura, a unit of GE Healthcare (NYSE: GE), to provide worldwide
brachytherapy loading services to Oncura. Under the three-year
agreement, Theragenics will load and package Oncura manufactured
brachytherapy seeds in prescription loaded needles, custom strands and
other configurations. Oncura's iodine-125 brachytherapy seeds are
utilized primarily in the treatment of early stage prostate cancer. This
agreement provides for loading services for most Oncura sales of
prescription and custom loaded brachytherapy seeds worldwide, which
currently includes North America, Europe, Australia and portions of Asia.


See full press release

Posted-In: Earnings News Guidance Contracts Management Global


Related Articles (GE + TGX)

View Comments and Join the Discussion!

Partner Center